AstraZeneca has reported a big enhance in sales for the primary half of 2026, pushed primarily by sturdy demand for its cancer and uncommon illness treatments, even because the pharmaceutical big elevated its funding in new analysis. The Cambridge-based agency noticed whole revenues climb 6% at fixed alternate charges to $30.67 billion (£22.99 billion). Its…
Key occasions Elsewhere on the company entrance this morning, Vodafone has reported a 9.7% rise in income in its first quarter to €10.3bn. Service income rose 5% within the quarter led to June, in contrast with investor expectations of a 4.6% acquire. Management now expects that its adjusted earnings will attain someplace between €13bn to…
Image supply: Getty Images The AstraZeneca (LSE:AZN) share price is approaching all-time highs. A latest catalyst, sending the shares shifting upwards by over 3%, was the report that its experimental lung illness medication hit its targets in two late-stage medical trials. This was seen as an actual therapy breakthrough. A breakthrough in COPD The drug in query…